Viveve Medical, Inc.
NASDAQ Capital Market•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Ms. Deborah Ann Jorn M.B.A.
- Full Time Employees
- 47
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Building B Englewood CO United States of America 80112
- IPO Date
- May 3, 2010
- CIK
- 0000879682
- Website
- viveve.com
- Similar Companies
- Business
- Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Company News
Why Is Viveve Medical (VIVE) Stock Down 69% Today?
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2022 Results - Earnings Call Transcript
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Viveve to Participate in H.C. Wainwright Global Investment Conference
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Viveve Medical Inc. (VIVE) CEO Scott Durbin on Q4 2021 Results - Earnings Call Transcript
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q3 2021 Results - Earnings Call Transcript
Viveve to Host Conference Call on November 11, 2021 to Report Third Quarter Financial Results and Provide Corporate Update
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Viveve to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q2 2021 Results - Earnings Call Transcript
Viveve Reports Second Quarter 2021 Financial Results and Provides Corporate Update
VIVE Stock Price Increases Over 3% Pre-Market: Why It Happened
Viveve Announces Continued Expansion of IP Portfolio with Issuance of Canadian Patent
Viveve to Participate in Ladenburg Thalmann Healthcare Virtual Conference
Viveve Announces Issuance of New Device and Methods Patent in U.S.
Viveve Announces Adjournment of Annual Meeting